[Idiopathic thrombocytopenic purpura: present knowledge and future expectations].
Delgado
P
P
Servicio Regional de Hematología y Hemoterapia, Hospital Miguel Servet, Zaragoza.
García-Zueco
J C
JC
Rubio-Félix
D
D
Giralt
M
M
D000328:Adult; D001323:Autoantibodies / Q000032:analysis / Q000276:immunology; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D016175:B-Lymphocyte Subsets / Q000276:immunology; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000628:therapy; D012075:Remission, Spontaneous; D012307:Risk Factors; D013156:Splenectomy; D013921:Thrombocytopenia / Q000151:congenital; D014777:Virus Diseases / Q000150:complications
D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents
Púrpura trombocitopénica idiopática: conocimientos presentes y expectativas de futuro.